David Young

6PUBLICATIONS

16CO-AUTHORS

Epidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jul 10, 2026

Real-World Effectiveness, Safety and Quality of Life With Ustekinumab for the Treatment of Crohn's Disease: Results of the UK Ustekinumab Real World Evidence Study (UndieS) Study Group.

|Feb 07, 2025

Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres.

David Young, Sohail Rahmany, Deborah Taylor

|Nov 27, 2024

Exploring Antibacterial Usage and Pathogen Surveillance over Five Years in a Tertiary Referral Teaching Hospital Adult General Intensive Care Unit (ICU).

David Young, Cathrine A McKenzie, Sanjay Gupta

|May 11, 2024

A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS).

David Young, Clare Harris, Sohail Rahmany

|Jul 19, 2022

Patient perspectives of successful adalimumab biosimilar transitioning in Crohn's disease: an interview study.

David Young, Fraser Cummings, Susan Latter

|Dec 17, 2021

Current evidence on the use of the adalimumab biosimilar SB5 (Imraldi<sup>TM</sup>): a multidisciplinary perspective.

Javier P Gisbert, Karl Gaffney, David Young

Pageof 1

Frequent Collaborators

J R Fraser Cummings

Susan Latter

Javier P Gisbert

Karl Gaffney

Giampiero Girolomoni

Clare Harris

Sohail Rahmany

Ahilanandan Dushianthan

1 joint publications

Kordo Saeed

1 joint publications

Cheryl Booker

Frequent Collaborators

J R Fraser Cummings

Susan Latter

Javier P Gisbert

Karl Gaffney